VanEck Biotech Valuation
| BBH Etf | USD 167.03 1.59 0.96% |
At this time, the etf appears to be fairly valued. VanEck Biotech ETF has a current Real Value of $167.71 per share. The regular price of the etf is $167.03. Our model measures the value of VanEck Biotech ETF from inspecting the etf fundamentals such as Total Asset of 478.42 M, price to earning of 17.66 X, and Number Of Employees of 6 as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that VanEck Biotech's price fluctuation is very steady at this time. Calculation of the real value of VanEck Biotech ETF is based on 3 months time horizon. Increasing VanEck Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since VanEck Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of VanEck Etf. However, VanEck Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 167.03 | Real 167.71 | Hype 167.07 | Naive 170.07 |
The intrinsic value of VanEck Biotech's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence VanEck Biotech's stock price.
Estimating the potential upside or downside of VanEck Biotech ETF helps investors to forecast how VanEck etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of VanEck Biotech more accurately as focusing exclusively on VanEck Biotech's fundamentals will not take into account other important factors: About VanEck Biotech Valuation
An absolute valuation paradigm, as applied to VanEck Etf, attempts to find the value of VanEck Biotech ETF based on its fundamental and basic technical indicators. By analyzing VanEck Biotech's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of VanEck Biotech's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of VanEck Biotech. We calculate exposure to VanEck Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of VanEck Biotech's related companies. When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in VanEck Biotech ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.